Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Both ingredients offer valuable skin benefits, and the choice depends on your skins condition, skincare goals, and preferences
In individuals with elevated baseline AST/ALT (non-alcoholic fatty liver, alcohol use, medication-related elevation), clinical studies have documented measurable enzyme normalization in the 4-8 week window